The amount Medicare pays per RVU gets its first substantial boost in years, but most of the increase will expire at the end of 2026 unless Congress acts. Editor's note: This article was updated to ...
CMS has added 10 new procedure codes to the list of procedures Medicare pays ASCs to perform, according to an Oct. 8 transmittal outlining the agency’s October 2026 ASC payment system update. The ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ (bevacizumab-vikg, bevacizumab gamma) for the treatment of retinal ...
ISELIN - Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA (bevacizumab-vikg, bevacizumab gamma) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results